RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Anna Schwartz to Antineoplastic Agents

This is a "connection" page, showing publications Anna Schwartz has written about Antineoplastic Agents.
Connection Strength

0.951
  1. Bae EH, Greenwald MK, Schwartz AG. Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues. Neurotherapeutics. 2021 10; 18(4):2384-2396.
    View in: PubMed
    Score: 0.472
  2. Schwartz AL, Winters-Stone K, Gallucci B. Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum. 2007 May; 34(3):627-33.
    View in: PubMed
    Score: 0.173
  3. Schwartz AL, Thompson JA, Masood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum. 2002 Aug; 29(7):E85-90.
    View in: PubMed
    Score: 0.124
  4. Schwartz AL, Meek PM, Nail LM, Fargo J, Lundquist M, Donofrio M, Grainger M, Throckmorton T, Mateo M. Measurement of fatigue. determining minimally important clinical differences. J Clin Epidemiol. 2002 Mar; 55(3):239-44.
    View in: PubMed
    Score: 0.121
  5. Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors. Cancer. 2012 Apr 15; 118(8 Suppl):2270-6.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support